Genetic health reports are powerful. They can surface real, research-backed connections between your DNA variants and how your body works. But they’re not crystal balls, and treating them like one does more harm than good.

If you’ve taken a test from AncestryDNA or 23andMe and you’re thinking about uploading your raw data for deeper analysis, you deserve an honest picture of what these reports can and can’t do. So let’s talk about the boundaries.

Your DNA is probabilistic, not deterministic

This is the single most important thing to understand about genetic health reports: they deal in probabilities, not certainties.

When a report says you carry a variant associated with higher type 2 diabetes risk, it doesn’t mean you’ll develop diabetes. It means that in large research studies, people with that variant had a statistically higher chance of developing the condition compared to people without it.

Take the TCF7L2 gene variant rs7903146 as an example. It’s one of the strongest common genetic risk factors for type 2 diabetes, with a per-allele odds ratio of about 1.4. That’s meaningful in a research context. But your actual risk depends on dozens of other factors: your diet, your activity level, your sleep, your stress, your other genetic variants, and interactions between all of these.

Carrying a risk variant doesn’t seal your fate. Not carrying one doesn’t guarantee you’re safe.

Genotyping chips only read a fraction of your genome

Here’s something that surprises most people: consumer DNA tests don’t read your whole genome. Not even close.

A genotyping chip from AncestryDNA or 23andMe measures roughly 600,000 to 700,000 SNPs (single nucleotide polymorphisms). That sounds like a lot, and it is. But the human genome contains over 6 billion base pair positions. Your genotyping chip is reading about 0.01% of them.

The SNPs on these chips were selected because they’re common, well-studied, and informative for ancestry estimation and certain health traits. But they miss entire categories of genetic variation:

Structural variants (insertions, deletions, duplications of larger DNA segments)
Copy number variations (where sections of the genome are repeated different numbers of times)
Variants in non-coding regions that haven’t been well-characterized yet
Rare variants unique to your family or ethnic group

A genotyping chip is like reading every 10,000th word in a very long book. You’ll pick up on major themes, but you’ll miss plenty of important details.

Rare variants fly under the radar

Genotyping chips are designed to capture common variants, the ones that appear in at least 1-5% of the population. This makes sense from a research perspective: common variants have enough carriers to study statistically.

But some of the most impactful genetic variants are rare. Whole genome sequencing (WGS) can identify millions of variants per person, including rare ones that might be clinically significant. A genotyping chip won’t catch those.

This doesn’t make genotyping useless. It means you should understand the scope of what you’re seeing. A clean report doesn’t mean your genome is free of notable variants. It means the notable variants that were tested came back unremarkable.

The ancestry bias problem in genetic research

This one matters more than most people realize.

The vast majority of genome-wide association studies (GWAS) have been conducted on populations of European descent. That research bias flows directly into consumer genetic reports, because the risk estimates and effect sizes cited in those reports come from those same studies.

You can see this clearly in real SNP data. Look at how population-specific the research gets:

rs7903146 (TCF7L2): The risk allele frequency varies dramatically: ~30% in European populations, ~50% in African populations, and just ~5% in East Asian populations. Yet the effect size cited in most reports comes from European cohort studies.
rs9923231 (VKORC1): This variant, critical for warfarin dosing, has a frequency of ~40% in Europeans, ~90% in East Asians, and ~10% in Africans. Dosing algorithms calibrated primarily on European data may not translate directly.
rs334 (HBB): The sickle cell variant reaches ~8% carrier frequency in African Americans and up to 25% in some West African populations, while it’s essentially absent in European and Asian populations. This is an example where population-specific context is everything.
rs4244285 (CYP2C19): This drug metabolism variant appears in ~15% of Europeans, ~30% of East Asians, and ~17% of Africans. A report calibrated on European frequencies could mischaracterize its significance for other groups.

Out of the 256 SNPs in a well-curated reference database, a striking number have population notes that reference European-specific frequencies, simply because that’s where the deepest research exists. Variants that matter most in African, East Asian, South Asian, or Indigenous populations are underrepresented in the literature, and therefore in the reports built on that literature.

If you’re not of European descent, your genetic report may be less precise. Not because the technology doesn’t work, but because the research it draws on is less complete for your background. Honest reports should tell you this directly.

Your genes don’t operate in a vacuum

Even when a variant is well-studied and the statistics are solid, your DNA is only one layer of the story. Gene-environment interactions shape outcomes in ways that a genetic report alone can’t capture.

Consider the MTHFR gene variant rs1801133 (C677T). Homozygous carriers have about 70% reduced enzyme activity, which can lead to elevated homocysteine. That sounds concerning. But the clinical significance depends heavily on your folate intake. With adequate dietary folate, many carriers show completely normal homocysteine levels. The variant sets a tendency; your environment determines whether that tendency plays out.

This pattern repeats across the genome:

FTO (rs9939609): The obesity-associated variant’s effect is significantly reduced in physically active people. Exercise doesn’t change your genotype, but it changes what your genotype means for your weight.
APOA2 (rs5082): This variant’s effect on lipid metabolism depends on dietary saturated fat intake. The gene-diet interaction has been replicated in multiple cohorts.
CYP1A1 (rs1048943): This detoxification gene variant increases activation of environmental carcinogens, but that only matters if you’re exposed to those carcinogens. Smokers with this variant face a different risk profile than non-smokers.

Then there’s epigenetics: chemical modifications to your DNA that turn genes on and off without changing the underlying sequence. Your diet, stress levels, sleep, toxin exposure, and even your gut microbiome influence your epigenetic landscape. A genetic report captures your sequence. It can’t capture the layers of regulation sitting on top of it.

So what are genetic reports actually good for?

After all those caveats, you might wonder if genetic reports are worth anything. They absolutely are. You just need to calibrate your expectations.

A well-built genetic health report gives you:

Directional insights, not diagnoses. It highlights areas where your genetics suggest you might benefit from paying closer attention, whether that’s cardiovascular health, nutrient metabolism, or drug interactions.
A starting point for conversations with healthcare providers. “My genetic report flagged a VKORC1 variant relevant to warfarin dosing” is useful information for a doctor to have.
Personalized context for general health advice. Knowing you carry variants affecting vitamin D metabolism (VDR/GC genes) makes “take vitamin D” less generic and more personally relevant.
Motivation grounded in biology. Understanding why your body responds to exercise, caffeine, or certain foods the way it does can make lifestyle changes feel less arbitrary.

What it doesn’t give you is a complete picture. Your genetics are one input alongside your blood work, your wearable health data, your family history, your lifestyle, and your clinical assessments.

Why honest reporting matters

Here’s where this gets personal for us. At SoDNAscan, we built confidence scores into every finding in your health book. Every variant we report on includes its evidence tier, effect size, and population context, because you deserve to know how strong the science actually is.

Some genetic testing services present every finding with equal weight, as if a variant backed by hundreds of studies and an odds ratio of 3.5 is the same as an emerging association with modest evidence. That’s not transparency. It’s noise.

We also tell you explicitly when research for a given variant has been conducted primarily in specific populations. If you’re of non-European descent and a finding is based heavily on European cohort data, your report should say so. Ours does.

Genetic reports don’t need to be perfect to be useful. They need to be honest about their own limitations. When you know what the data can and can’t tell you, you’re in a much better position to actually use it.

Your DNA is one piece of the puzzle. A genuinely useful health report treats it that way.

What Genetic Health Reports Can't Tell You (and Why That's OK)